A contract manufacturing organization ( CMO ), more recently referred to (and more commonly used now) as a contract development and manufacturing organization ( CDMO ) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing . This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
33-549: Services offered by CDMOs include, but are not limited to: CDMOs are contract manufacturers , yet they provide development as a standard part of their services. Their customers are not only expecting competitive pricing, but also regulatory compliance, flexibility on the production capability and on-time delivery. Overall it is required that CMO complies with good manufacturing practice from their client and regulatory bodies such as Food and Drug Administration . The pharmaceutical market uses outsourcing services from providers in
66-403: A $ 14 billion business segment around 2022. In the semiconductor industry, this practice is called the foundry model . Contract manufacturing is specially prevalent in the electronics industry . There are many benefits as well as risks to contract manufacturing. Companies are finding many reasons why they should outsource their production to other companies. However, production outside of
99-568: A CDMO may be a faster and less costly solution than developing new manufacturing capabilities. The pharmaceutical client using the services of a CDMO does not have direct control of the project in regard to scheduling, cost, quality , or accountability yet should be heavily invested to work closely with the CDMO partner to ensure success. Data security can be an issue when considering a CDMO, as intellectual property and other proprietary data are exchanged between client and service provider. One of
132-406: A capacity of more than 360,000 liters, making it the world's largest contract-based manufacturer in the biopharmaceutical sector at a single site as of 2018. The industry has experienced an increase in private equity investment and this has led to the consolidation of choices in the CDMO industry as many larger CDMOs have been formed. Many of those are active at aiming to be larger scale suppliers in
165-429: A general manner, quality in business consists of "producing a good or service that conforms [to the specification of the client] the first time, in the right quantity, and at the right time". The product or service should not be lower or higher than the specification (under or overquality). Overquality leads to unnecessary additional production costs. There are many aspects of quality in a business context, though primary
198-419: A good business strategy . For large companies that are trying to extend into new markets, contract manufacturing may be a good choice. In an international context, establishing a foreign subsidiary as a contract manufacturer can have favorable tax benefits for the parent company, allowing them to reduce overall tax liabilities and increase profits, depending upon the activities of the contract manufacturer. This
231-477: A hiring firm will request quotes from multiple CMs. After the bidding process is complete, the hiring firm will select a source, and then, for the agreed-upon price, the CM acts as the hiring firm's factory, producing and shipping units of the design on behalf of the hiring firm. Job production is, in essence, manufacturing on a contract basis, and thus it forms a subset of the larger field of contract manufacturing. But
264-413: A pragmatic interpretation as the non-inferiority or superiority of something ( goods or services ); it is also defined as being suitable for the intended purpose (fitness for purpose) while satisfying customer expectations. Quality is a perceptual, conditional, and somewhat subjective attribute and may be understood differently by different people. Consumers may focus on the specification quality of
297-457: A product/service, or how it compares to competitors in the marketplace. Producers might measure the conformance quality , or degree to which the product/service was produced correctly. Support personnel may measure quality in the degree that a product is reliable , maintainable , or sustainable . In such ways, the subjectivity of quality is rendered objective via operational definitions and measured with metrics such as proxy measures . In
330-430: A significant part of the design and customization process if needed. Some turnkey suppliers specialize in one base component (e.g. memory chips ) or a base process (e.g. plastic molding). In a contract manufacturing business model, the hiring firm approaches the contract manufacturer with a design or formula. The contract manufacturer will quote the parts based on processes, labor, tooling, and material costs. Typically
363-401: A slow but gradual movement among manufacturers away from a "maximum production" philosophy to one aligned more closely with "positive and continuous control of quality to definite standards in the factory." That standardization, further pioneered by Deming and Juran later in the twentieth century, has become deeply integrated into how manufacturing businesses operate today. The introduction of
SECTION 10
#1732780111859396-516: Is a form of true protectionism . The iPad and iPhone , which are products of Apple Inc. , are manufactured in China by Foxconn . Some devices may also be manufactured by Pegatron . Apple may move some fraction of iPhone assembly into the United States in the near future. Quality (business) In business , engineering , and manufacturing , quality – or high quality – has
429-518: Is a manufacturer that contracts with a firm for components or products (in which case it is a turnkey supplier ). It is a form of outsourcing . A contract manufacturer performing packaging operations is called copacker or a contract packager . Brand name companies focus on product innovation , design and sales, while the manufacturing takes place in independent factories (the turnkey suppliers). Most turnkey suppliers specialize in simply manufacturing physical products, but some are also able to handle
462-624: Is coming from CMO that are acquiring manufacturing site from bio/pharma companies. In 2017, Pfizer established a manufacturing site in Liscate, Italy , which was followed that same year by AstraZeneca in Reims, France . Novartis Sandoz acquired a site in Boucherville, Canada in 2018, as well as Glaxo Smith Kline , which began manufacturing out of South Carolina in the United States . Samsung Biologics built three manufacturing plants with
495-479: Is the idea the business produces something, whether it be a physical good or a particular service. These goods and/or services and how they are produced involve many types of processes, procedures, equipment, personnel, and investments, which all fall under the quality umbrella. Key aspects of quality and how it's diffused throughout the business are rooted in the concept of quality management : While quality management and its tenets are relatively recent phenomena,
528-789: The ISO 9001, 9002, and 9003 standards in 1987 — based on work from previous British and U.S. military standards — sought to "provide organizations with the requirements to create a quality management system (QMS) for a range of different business activities." Additionally, good manufacturing practice (GMP) standards became more common place in countries around the world, laying out the minimum requirements manufacturers in industries including food and beverages , cosmetics , pharmaceutical products , dietary supplements, and medical devices must meet to assure their products are consistently high in quality. Process improvement philosophies such as Six Sigma and Lean Six Sigma have further pushed quality to
561-450: The financial crisis of 2007–2008 , 75% of the candidate that outsourced services were small and mid-sized biotechnology and pharmaceutical companies. Following the financial crash in 2008 the CMO industry started to be funded by private equity as a result of a substantial growth and a more qualified management. The one-stop CDMO concept could be the direction the industry is heading by offering
594-457: The CDMO environment but the number of attractive acquisitions are limited. One could argue that this has had both positive and negative effects on the industry. Larger pharma companies like the idea of a larger CDMO while smaller pharma companies tend to see it more difficult to get the kind of service they expect. The bio/pharma companies used to build and staff dedicated manufacturing capacities for drugs in development only to see them canceled if
627-461: The company has many risks attached. Companies must first identify their core competencies before deciding about contract manufacturers. A company's competencies are what make them competitive in the marketplace . If a company allows another company to take control of them, it loses that advantage. When deciding about contract manufacture, the company should weigh the benefits and associated risks. For small companies, contract manufacturing may not be
660-430: The concept of quality into the functions of the service industry takes a slightly different path from manufacturing. Where manufacturers focus on "tangible, visible, persistent issues," many — but not all — quality aspects of the service provider's output are intangible and fleeting. Other obstacles include management's perceptions not aligning with customer expectations due to lack of communication and market research and
693-823: The contracting (also called outsourcing) of manufacturing to countries like China and India, as well internationalization of trade and competition. These countries, among many others, have raised their own standards of quality in order to meet international standards and customer demands. The ISO 9000 series of standards are probably the best known international standards for quality management, though specialized standards such as ISO 15189 (for medical laboratories) and ISO 14001 (for environmental management) also exist. The business meanings of quality have developed over time. Various interpretations are given below: Traditionally, quality acts as one of five operations/project performance objectives dictated by operations management policy. Operations management, by definition, focuses on
SECTION 20
#1732780111859726-507: The forefront of business management and operations. At the heart of these and other efforts is often the QMS, a documented collection of processes, management models, business strategies, human capital, and information technology used to plan, develop, deploy, evaluate, and improve a set of models, methods, and tools across an organization for the purpose of improving quality that aligns with the organization's strategic goals. The push to integrate
759-412: The form of contract research organizations (CROs) who work on very early-stage drug development on very small scale providing medicinal chemistry services. These are now often called CDROs as they provide some small scale development work. CDMOs work on the scale-up and later stages of drug development often preparing materials ranging from hundreds of grams to multi-kilo amounts. As the drug moves through
792-553: The idea of quality in business is not new. In the early 1900s, pioneers such as Frederick Winslow Taylor and Henry Ford recognized the limitations of the methods being used in mass production at the time and the subsequent varying quality of output, implementing quality control, inspection, and standardization procedures in their work. Later in the twentieth century, the likes of William Edwards Deming and Joseph M. Juran helped take quality to new heights, initially in Japan and later (in
825-611: The improper or lack of delivery of skill-based knowledge to personnel. Like manufacturing, customer expectations are key in the service industry, though the degree with which the service interacts with the customer definitely shapes perceived service quality. Perceptions such as being dependable, responsive, understanding, competent, and clean (which are difficult to describe tangibly) may drive service quality, somewhat in contrast to factors that drive measurement of manufacturing quality. In Japanese culture, there are two types of quality: atarimae hinshitsu and miryokuteki hinshitsu . In
858-407: The increasing demand for outsourced services. The best-positioned service providers focus on a specific technology or dosage form and promote end-to-end continuity and efficiency for their outsourcing clients. With lower-cost international manufacturers capturing an increasing percentage of the contract manufacturing market, specialization may be an effective hedge against loss of market share. Before
891-408: The late '70s and early '80s) globally. Customers recognize that quality is an important attribute in products and services, and suppliers recognize that quality can be an important differentiator between their own offerings and those of competitors (the quality gap). In the past two decades this quality gap has been gradually decreasing between competitive products and services. This is partly due to
924-677: The latter field also includes, in addition to jobbing, a higher level of outsourcing in which a product-line-owning company entrusts its entire production to a contractor, rather than just outsourcing parts of it. Many industries use this process, especially the aerospace , defense , computer , semiconductor , energy , medical , food manufacturing , personal care , packaging , and automotive fields. Some types of contract manufacturing include CNC machining, complex assembly, aluminum die casting, grinding, broaching, gears, and forging. The pharmaceutical industry uses this process with CMs called contract manufacturing organizations , constituting
957-630: The major risk remains in the lack of control over the CDMO's compliance for the client, for example when an FDA warning letter is issued, a resulting interruption of production may result in major delay or interruption of shipping thus it is critical to properly vet the selected CDMO. The rise of the CDMO industry led to an increase of inspectors from various divisions of the Food and Drug Administration (e.g.: Center for Biologics Evaluation and Research or Center for Drug Evaluation and Research ). Contract manufacturer A contract manufacturer ( CM )
990-523: The most effective and efficient ways for creating and delivering a good or service that satisfies customer needs and expectations. As such, its ties to quality are apparent. The five performance objectives which give business a way to measure their operational performance are: Based on an earlier model called the sand cone model, these objectives support each other, with quality at the base. By extension, quality increases dependability, reduces cost, and increases customer satisfaction. The early 1920s saw
1023-476: The product failed in Phase III of clinical research ; working with a CDMO limits that financial risk. Using a CDMO also allows drug and biologic manufacturers to get advantage of specific expertise and capability. Some CDMOs are specialized in manufacturing of specialty products or formulations which some pharmaceutical companies may not have the capability to produce in-house. In these situations, contracting with
Contract manufacturing organization - Misplaced Pages Continue
1056-429: The various clinical stages, the volumes tend to grow as well. Commercial scale amounts could range to metric tons. Over the years, the concept of a comprehensive single-source provider from drug development (a one-stop shop) through commercial manufacture of drug substance and drug product has been tried to varying success. CDMOs are a response to the competitive international nature of the pharmaceutical market as well as
1089-436: The whole spectrum of development services (e.g. development, production and analysis). The acquisitions that have been finalized in 2017 in CMO and CDMO industry brought some of these companies to a level that allows them to compete with global bio/pharma companies. The value of the mergers and acquisitions in 2017 was likely to exceed $ 20 billion, below are some examples of these M&A: Another aspect of these acquisitions
#858141